הפודקאסטים הטובים ביותר ב-Rheumatology (2025)

1
Xue Li on access to biologics in the Asia-Pacific region 19:31

2d ago19:31

19:31

This is a joint podcast between The Lancet Rheumatology and The Lancet Regional Health - Western Pacific with Prof Xue Li. Biologics have become a mainstay of treatment in Rheumatology in Western populations, but in many parts of Asia, especially lower-and-middle-income countries, there remains substantial inequity in access due to differences in a…

1
Ep 30. GUIDELINES - BSR management recommendations for ANCA-associated vasculitis 2025 22:23

7d ago22:23

22:23

BSR has published a new set of management recommendations for ANCA-associated vasculitis (AAV), serving as an update to our AAV guideline last published in 2017. Find out more via our blog. Join guideline working group Chair, Lorraine Harper, and group members Rosemary Hollick, Harold Wilson-Morkeh, Georgina Ducker and expert by experience member, …

1
e124: MTX vs Pred for Pulmonary Sarcoidosis: PREDMETH Study 14:18

11d ago14:18

14:18

Interesting NEJM trial this week comparing methotrexate to prednisone for pulmonary sarcoidosis. Paper available here: https://www.nejm.org/doi/full/10.1056/NEJMoa2501443על ידי Michael Putman

1
Ep 50. Modifiable risk factors and therapeutic targets in polymyalgia rheumatica 9:22

11d ago9:22

9:22

How can we identify modifiable risk factors and new therapeutic targets in polymyalgia rheumatica? In this episode, recorded live at BSR25, Prof Ernest Choy and Dr Steven Zhao discuss Steven's genome-wide meta-analysis and Mendelian randomisation study. They cover the key findings, which include some novel loci and potential therapeutic targets for…

1
Sinisa Savic on treatment outcomes in VEXAS syndrome 12:07

6d ago12:07

12:07

In this podcast, Professor Savic talks about his recent publication that looks at treatment outcomes in patients with VEXAS syndrome, as well as what clinicians should look out for in patients (red flags), and future priorities for research. VEXAS syndrome (short for Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome) was first descr…

1
Fabian Müller and Melanie Hagen on a newly discovered toxicity of CD-19 targeting CAR T-cell therapy 20:50

20d ago20:50

20:50

This is the third and final episode of our mini-series on cell-based therapies in rheumatology, with Professor Fabian Müller and Dr Melanie Hagen from the Erlangen University, Germany. We discuss their recently published a study on a newly discovered toxicity of CD-19 targeting CAR T-cell therapy in patients with autoimmune disease, as well as the …

1
BONUS EPISODE: Mental health and burnout in the rheumatology MDT 40:32

1M ago40:32

40:32

This Talking Rheumatology Spotlight pod on burnout and mental health was recorded live at the BSR Annual Conference 2025. Pip Watson is joined by Gail Kinman (Professor of Occupational Health Psychology), Muzaffer Kaser (Consultant Psychiatrist) and Jacqui Clinch (Consultant Paediatric Rheumatologist and former Vice President of BSR). Burnout is a …

1
Ep 46: The Immunology of Lupus 43:17

2M ago43:17

43:17

Join Dr Mariele Gatto in conversation with Dr Chris Wincup as they discuss all things related to lupus immunology, from pathogenesis to treatment decisions. Thanks for listening to Talking Rheumatology! Join the conversation on X using #TalkingRheum or tweet us @RheumatologyUK. BSR is the UK's leading specialist medical society for rheumatology and…

1
Ep 49. Improving time to diagnosis in axial spondyloarthritis 10:45

2M ago10:45

10:45

How can we improve time from symptom onset to axSpA diagnosis? In this episode, Dr Fabian Proft talks to Dr Antoni Chan about his fantastic work to reduce time to diagnosis in axial spondyloarthritis (axSpA) using an integrated referral and education system. They discuss the importance of a multi-pronged approach to education, as well as how clinic…

1
Ep 45: Immunology in the virtual biologics clinic 32:26

2M ago32:26

32:26

How do we approach a patient with rheumatic diseases who have cycled through multiple high cost drugs? In this pod, Dr Roz Benson, BSR Digital Learning Editor chats with Dr Arti Mahto, a consultant rheumatologist. They talk through some challenging cases discussed in the virtual biologics clinic and the role of the MDT in complex decision making. T…

1
E123: Upadacitinib for Giant Cell Arteritis: SELECT-GCA 18:13

2M ago18:13

18:13

Podcast this week about the recently published SELECT-GCA study, which evaluated the use of the janus kinase inhibitor upadacitinib (Rinvoq) for patients with new and relapsing GCA. Successful trial and an interesting topic. Paper itself here: https://www.nejm.org/doi/full/10.1056/NEJMoa2413449על ידי Michael Putman

1
Dominique Farge on allogeneic umbilical cord-derived mesenchymal stromal cells for systemic lupus erythematosus 26:05

2M ago26:05

26:05

This is the second episode of a mini series on cell-based therapies in rheumatology, with Prof. Dominique Farge discussing the use of allogeneic umbilical cord-derived mesenchymal stromal cells (MSCs) as treatment for systemic lupus erythematosus (SLE). We cover the limited options currently available for people with severe or refractory SLE, the c…

1
E122: Guidelines for Maybe Diagnosing HLH 11:18

2M ago11:18

11:18

This week I cover another of my newsletters, though I mostly use it as a skeleton to riff on a common (and challenging) issue for rheumatology consultants; diagnosing HLH. Check out the guidelines themselves here and have a listen to the podcast! https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(23)00273-4/fulltext…

1
Ep 29. GUIDELINES - BSR axial spondyloarthritis guideline 2025 19:43

3M ago19:43

19:43

BSR has published an update to the axial spondyloarthritis guideline. It's almost 10 years since the last iteration of the guideline. Our understanding and awareness of the disease has increased enormously. We now have 10 different therapies licensed for advanced management of axial spondyloarthritis, which are broadly divided into three different …

1
E121: Obinutuzumab in SLE-LN 18:14

3M ago18:14

18:14

Another day, another b cell podcast. Seems to be all the rage! This week I discuss the recently published NEJM trial of the anti CD20 agent obinutuzumab in lupus nephritis. Worth a read and listen, paper can be found here: https://www.nejm.org/doi/full/10.1056/NEJMoa2410965על ידי Michael Putman

1
BONUS CASE: Muscle weakness 19:06

3M ago19:06

19:06

In this bonus case based episode Steph Gall from the BSR digital learning board discusses an interesting case of muscle weakness with Dr Lisa Waters a Consultant in Rheumatology and Acute Medicine from Manchester. Can you work out what's going on? Thanks for listening to Talking Rheumatology! Join the conversation on X using #TalkingRheum or tweet …

1
Rebecca Marsh and Grant Schulert on allogeneic HSCT for children with refractory sJIA and associated lung disease 18:30

3M ago18:30

18:30

The first episode of a mini series on cell-based therapies in rheumatology, with Prof Rebecca Marsh and Grant Schulert discussing the use of allogeneic haematopoietic stem-cell transplantation for children with refractory systemic juvenile idiopathic arthritis and associated lung disease. Read the full article: https://www.thelancet.com/journals/la…

1
Ep 28. GUIDELINES - BSR foot health in inflammatory arthritis guideline 14:32

3M ago14:32

14:32

BSR has published a new guideline for the assessment and management of foot problems in adults, children and young people with inflammatory arthritis. Foot problems are almost universal in people with inflammatory arthritis, and virtually all people with inflammatory arthritis will experience foot problems at some point in the course of their disea…

1
Ep 27. INNOVATORS - Improving care for prisoners in the rheumatology clinic 43:35

3M ago43:35

43:35

Roz Benson (digital learning editor) talks to consultant rheumatologist Dr Lizzy MacPhie and Resident doctor Nouran Abdou about a recent project digging deep into the reasons prisoners face difficulty in accessing care in the rheumatology clinic. This excellent project showcases how quality improvement can be a tool in helping to approach and reduc…

1
E120: Real Life Use of PEXIVAS-Low 24:33

4M ago24:33

24:33

What do you do when observational data and RCTs conflict? This week I'm covering the "real world PEXIVAS" study that was done by the French Vasculitis Study Group. Great read, interesting issues, have a listen and be sure to share with friends!על ידי Michael Putman

1
Ep 44: Fatigue and how to help patients, including insights from the LIFT trial 27:24

4M ago27:24

27:24

In this podcast, Jess Little, specialist MSK physiotherapist, talks to Professor Neil Basu, academic Rheumatologist and Professor Lorna Paul, professor of allied health science about fatigue and particularly what we can do to help patients. It covers everything from the importance to patients of considering fatigue to interventions including the ro…

1
Ep 43: Fatigue in children, adolescents and young people 35:44

4M ago35:44

35:44

In this podcast, Kathryn Rigler, Rheumatology specialist physiotherapist, talks to Poppy Greenman, Paediatric occupational therapist, covering how to talk to children and young people about fatigue, measuring fatigue and strategies to overcome it, with practical tips from an expert in this area Thanks for listening to Talking Rheumatology! Join the…

1
Bryant England on advanced therapies in US veterans with rheumatoid arthritis-associated interstitial lung disease 8:30

4M ago8:30

8:30

Dr Bryant England discusses the use of TNF-inhibitor versus non-TNF inhibitor biological or targeted synthetic DMARDs for treatment of rheumatoid arthritis-associated ILD, and the effects on survival and respiratory hospitalisation outcomes. Read the full article: https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(24)00265-0/fulltext?d…

1
E119: Teclistamab for Rheumatology Writ Large 10:52

4M ago10:52

10:52

One of my rare case-report podcasts, a topic that I typically avoid. The craze about CAR-T has also made me a little crazy, though, so I wanted to share what I think may be the ultimate destination for "more B cell depletion than rituximab" strategies. Article: https://www.nejm.org/doi/full/10.1056/NEJMc2407150…

1
Ep 42: A tricky case of ILD 39:22

5M ago39:22

39:22

Dr Ashely Elliot speaks to respiratory consultant Dr Nazia Chaudhuri about interstitial lung disease. This overview covers everything from diagnosing CTD- ILD and an evidenced based management approach to poor prognostic risk factors. Thanks for listening to Talking Rheumatology! Join the conversation on X using #TalkingRheum or tweet us @Rheumatol…

1
E118: The emerging risk of overdiagnosis in RA and PMR 16:02

5M ago16:02

16:02

Podcast this week about overdiagnosis! Currently one of my favorite topics and something that I think will be an emerging issue in our field. We recently published a Viewpoint in Lancet Rheumatology (https://pubmed.ncbi.nlm.nih.gov/39341221/) addressing this issue. I'm going to read from it and after that will be giving a few final (spicy) thoughts…

1
Brooke Conley and Ivan Lin on the development of arthritis educational resources for Aboriginal and Torres Strait Islander peoples in Australia 18:30

5M ago18:30

18:30

Dr Brooke Conley and Associate Professor Ivan Lin discuss their recent study on integrating evidence from lived experience of Aboriginal people and clinical practice guidelines to develop arthritis educational resources. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup h…

1
BONUS CASE: Trust your gut, it has the answer- a challenging clinical case 23:44

6M ago23:44

23:44

In this Talking Rheumatology bonus case based episode Dr Roz Benson talks to Dr Susie Brockbank about an interesting and unusual case involving joint pain, GI involvement and some other systems. Can you work out what's going on? Thanks for listening to Talking Rheumatology! Join the conversation on X using #TalkingRheum or tweet us @RheumatologyUK.…

1
Mark Russell and Sherry Yang on the inequities in rheumatological care in the UK and USA 25:28

6M ago25:28

25:28

Dr Mark Russell and Sherry Yang discuss the factors influencing initiation of biologics in underserved populations with rheumatoid arthritis in the UK, how historical redlining and present-day racialised economic segregation affects health-care utilisation of adults with rheumatic diseases in the USA, and health inequities seen in rheumatology more…

1
BONUS CASE: an unusual cause of chest pain presenting to rheumatology 28:13

6M ago28:13

28:13

In this Talking Rheumatology bonus case based episode Dr Laura Chadwick talks to Prof Rob Moots about an interesting and unusual case involving joint pain and chest pain . Can you work out what's going on? Thanks for listening to Talking Rheumatology! Join the conversation on X using #TalkingRheum or tweet us @RheumatologyUK. BSR is the UK's leadin…

1
Ep 41: Vasculitis 57:41

6M ago57:41

57:41

In this pod, Roz Benson talks to consultant nurse Sarah Hardy and vasculitis expert Dr Shirish Dubey. This wide ranging discussion about vasculitis covers everything from diagnostic tips and approach to management, to the practicalities of a kidney biopsy and cyclophosphamide counselling. Thanks for listening to Talking Rheumatology! Join the conve…

1
Ep 26. INNOVATORS - Leading transformation as a Chief Registrar 24:06

6M ago24:06

24:06

In this episode of our Innovators mini-series, Amanda Mootoo, Mariam Malik and Nick Sands join Lizzy MacPhie to explore the role of a Chief Registrar. Whether you're a trainee interested in the Chief Registrar role and how it gives unique access to leadership and management training and experience, or if you are a member of a senior management team…

1
Ep 25. CAREERS - How to fail with Will Gregory 30:12

7M ago30:12

30:12

This is the second episode of a mini-series hosted by Dr Judith Jade where she explores the importance of our response to failure with prominent leaders in rheumatology. In this episode Dr Judith Jade talks to Will Gregory, a Rheumatology Consultant Physiotherapist at Salford Royal Hospital and our new BSR Vice President, about things that didn't g…

1
E117: Inebilizumab for IgG4-RD (MITIGATE) 12:55

7M ago12:55

12:55

New RCT in a new disease with a new drug! But is it as shiny as one would hope? Interesting discussion today about what a trial means, how it will affect practice, and how we could do better as a field. Happy holidays everyone!על ידי Michael Putman

1
Quirine Dumoulin on the 4-year data from the TREAT-EARLIER trial 15:38

7M ago15:38

15:38

Dr Quirine Dumoulin discusses the efficacy of a 1-year course of methotrexate on the development of rheumatoid arthritis in ACPA-negative people with clinically suspect arthralgia and predicted increased risk of rheumatoid arthritis. Read the full article: https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(24)00196-6?dgcid=buzzsprout_i…

1
Ep 24. INNOVATORS - Pioneering cost-effective biologics prescribing with a shared decision making tool 33:00

7M ago33:00

33:00

Can a new web tool drive shared decision making and cost effective biologics prescribing across NHS trusts? In this episode of our Innovators mini-series, Emily Rose-Parfitt and Philip Hamann join Lizzy MacPhie to showcase the truly pioneering RxInvolve web tool, which aids shared and clinical decision making for biologics prescribing. With patient…

1
E116: A New Paradigm for PMR 9:29

7M ago9:29

9:29

Reading one of my recent newsletters this week, this one about PMR tapers. Be sure to subscribe at ebrheum.com if you want access to the visuals and upcoming editions!על ידי Michael Putman

1
Ep 40. Understanding antibody testing in myositis and systemic sclerosis 33:17

8M ago33:17

33:17

In this pod Dr Stephanie Gall speaks with Professor Marina Anderson and Dr Sarah Tansley. Listen in to better understand how to interpret antibody results in patients with systemic sclerosis, myositis and their overlaps. They’ll cover the clinical patterns seen and how to weed out false positive results. Thanks for listening to Talking Rheumatology…

1
Ep 23. CAREERS - How to fail with Prof. David Isenberg 31:35

8M ago31:35

31:35

This is the first episode of a mini-series hosted by Dr Judith Jade where she explores the importance of our response to failure with prominent leaders in rheumatology. In this episode Dr Judith Jade talks to Prof David Isenberg, one of our leading academic Rheumatologists, about things that didn't go to plan. He candidly shares his experience incl…

1
E115: Benralizumab for EGPA - the MANDARA Study 9:52

8M ago9:52

9:52

Quick rundown of an important rheumatology RCT this week, discussing the IL-5 inhibitor benralizumab for the treatment of relapsing/refractory EGPA. MANDARA Study: https://www.nejm.org/doi/full/10.1056/NEJMoa2311155על ידי Michael Putman

1
Ep 48. Deciphering difficult-to-treat psoriatic arthritis 17:36

8M ago17:36

17:36

Should there be distinct definitions for difficult-to-treat and complex-to-manage psoriatic arthritis? In this episode of Talking Rheumatology Research, Dr Fabian Proft and Dr Andre Ribeiro join Dr Ai Lyn Tan to discuss their work to define difficult-to-treat psoriatic arthritis, as part of GRAPPA's wider D2T-PsA project. Find out more: Deciphering…

1
Ep 22. INNOVATORS - Championing change in axial SpA care - the NASS Changemakers 27:34

8M ago27:34

27:34

Meet the NASS Changemakers In the second of the INNOVATOR series, host Dr Lizzy MacPhie talks to guests as they discuss three award-winning projects, working between primary and secondary care to improve diagnosis and management for people with inflammatory back pain. With varying size projects, led by different members of the MDT, there’s somethin…

1
Sebastian Sattui on older adults with ANCA-associated vasculitis 25:54

8M ago25:54

25:54

Dr Sebastian Sattui discusses the effects of age and frailty on the risks of end-stage renal disease, death, and severe infection in older adults with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis. Read the full article: https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(24)00193-0/fulltext?dgcid=buzzsprout_icw_podca…

1
Ep 21. GUIDELINES - BSR-BAD Behçets living guideline 2024 24:59

8M ago24:59

24:59

BSR has co-published a living guideline with the British Association of Dermatologists for managing people of all ages with Behçets. Join guideline working group Co-Chairs, Ruth Murphy and Robert Moots, and members Clare Pain, Harry Petrushkin and Steve Higgins in a roundtable discussion hosted by Prof Ernest Choy. The living guideline is presented…

1
E114: Target Trials and STAR-RA with Rishi Desai 31:15

8M ago31:15

31:15

Important methodology podcast this week, covering a lot of ground with expert epidemiologist Rishi Desai. Really enjoyed our conversation and glad to be publishing today! **House Keeping Note: we actually recorded this ~15 months ago but I somehow lost the audio... which somehow re-appeared! #technology STAR-RA: https://pubmed.ncbi.nlm.nih.gov/3502…

1
Ep 20. Exploring patient initiated follow-up 19:21

9M ago19:21

19:21

How can patient initiated follow-up (PIFU) be successfully used in rheumatology services? Prof Laura Coates, Dr Mark Perry and Prof Raj Sengupta join Prof Ernest Choy to discuss their experiences of implementing PIFU. They offer some top tips for those starting their PIFU journey and highlight fantastic new resources available via BSR. Want to find…

1
Ep 39. CAR T-Cell Therapy 41:26

9M ago41:26

41:26

In this spotlight podcast Dr Roz Benson talks with Dr Chris Wincup and Dr Reuben Benjamin. Listen in if you want to understand better what all the buzz is around CAR T cell therapy and its applications in SLE and other CTDs. Want to know more? There are lots of Lupus resources to explore: Explore our Lupus sotlight - these digital learning resource…

1
Ep 38. Lupus 42:32

9M ago42:32

42:32

In this spotlight podcast Dr Pip Watson talks to Dr Chris Wincup about all things SLE- from guidelines to neuropsychiatric symptoms to personalised treatments for patients. Want to know more? There are lots of Lupus resources to explore: Explore our Lupus spotlight - these digital learning resources include a diagnosis and management webinar, a Lup…

1
E113: CAR-T is Coming to Rheumatology 14:04

9M ago14:04

14:04

Exciting podcast this week about the upcoming / impending use of CAR-T in rheumatology. Highly recommend rheumatologists learn about this now; it's going to be a big thing for many years to come. In a future episode I will lay out my case for skepticism, but for now I think a good run down of the first big published series will be enough! NEJM CAR-…

1
Celebrating 5 years of The Lancet Rheumatology with Oliver Distler, Laura Coates, and David Liew 58:02

9M ago58:02

58:02

To celebrate 5 years of The Lancet Rheumatology, international advisory board members Oliver Distler, Laura Coates, and David Liew discuss recent progress made, challenges to overcome, and future directions in rheumatology. Read the associated Editorial: https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(24)00245-5/fulltext?dgcid=buzzs…

פודקאסטים ששווה להאזין

פודקאסטים בנושא Rheumatology

פודקאסטים ששווה להאזין

מדריך עזר מהיר